Delivery Order SPE2DB22D1106-SPE2DB24FFAP1

Award Date 7/5/24
Potential Completion Date 7/8/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 18 mg Methylphenidate Extended Release (ER) tablets. The $1,344.34 firm fixed price delivery order has a completion date of July 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the delivery of Methylphenidate Extended Release 36 mg tablets. The contract, valued at $1,049.08, is a firm fixed price delivery order with a performance period through March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. In addition to this specific delivery...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,282.75 firm fixed-price contract is for the supply of 100 units of Methylphenidate Extended Release 36 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Methylphenidate ER 27 mg tablets. The firm-fixed-price contract is valued at $1,921.46 and has a period of performance through May 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methylphenidate Extended Release (ER) 36 mg tablets. The $2,505.66 firm fixed price delivery order, which does not have a set-aside designation, is a task order issued under a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA. The IDC, valued at up to $999,999,999.00, serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of 4,565,331,287 units of Methylphenidate Extended-Release 54 mg tablets. The contract has a firm fixed price of $2,004.23 and an ultimate completion date of August 5, 2024. This is a delivery order contract without any set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will provide these medications to support military treatment...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Methylphenidate ER 18 mg tablets in 100-count bottles. The contract, valued at $1,411.77, is a Firm Fixed Price Delivery Order that will be completed by June 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of methylphenidate extended-release 18 mg tablets. The contract, awarded on September 9, 2024, is a delivery order with a firm fixed price ceiling of $13,176.26 and a completion date of September 10, 2024. The contract does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, will supply the...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $13,578.87 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4,565,426,625 doses of methylphenidate extended-release 36mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical and medical supplies to...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the provision of methylphenidate extended-release (ER) 36 mg tablets. The contract has a ceiling value of $1,068.32 and a completion date of June 6, 2024. It is a firm-fixed-price contract with no set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is the prime contractor. This contract is part...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFAP1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methylphenidate Extended Release (ER) 36 mg tablets in 100-count bottles. The contract, valued up to $1,755.68, has a completion date of July 8, 2024 and uses a Firm Fixed Price pricing type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific delivery order does not have a set-aside designation.

Generated 10/4/24, 9:17 AM